Article and Video CATEGORIES
Videos from the webcast Targeted Therapies Patient Forum 2017 are available for viewing, and for those who prefer to read the material, GRACE has made all speaker presentations and handouts available. We have also included links to helpful social media and patient groups.
Again, huge thanks to all of the faculty who spent their Saturday in Cleveland with our community, and thanks also to those organizations who sponsored this event - Astra Zeneca, Takeda, Boehringer Ingelheim, Ignyta, Novartis, Genentech, Caris, and Guardant Health.
We started the day out with a warm welcome from our Forum Chair - Dr. Nathan Pennell. For the full agenda, faculty list, presentations, and videos from the webcast, please visit the 'webcast details' page, available via this link. For those who would like to view the presentations from the Targeted Therapies Patient Forum in Cleveland, please view and download all presentations and handouts here, or continue on for a list of what is available.
The morning sessions kicked off with a warm welcome from Dr. Pennell.
Dr. Nathan Pennell, Cleveland Clinic Cancer Center
Dr. Karen Reckamp, City of Hope Comprehensive Cancer Center
Dr. James P. Stevenson, Cleveland Clinic Cancer Center
Kathryn Sefcek, MHA, 4th Angel Mentoring Program
Dr. H. (Jack) West, Swedish Cancer Institute & Founder of cancerGRACE, and Janet Freeman-Daily, ROS1 patient, #LCSM Twitter Chat co- moderator, Cure Today contributor, blogger.
Please feel free to offer comments and raise questions in our Discussion Forums.
GRACE would like to thank the following sponsors for their support of this program
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi Stan,
It's so good to hear you and yours are doing well and that you were able to spend time with both families for Thanksgiving. I know it meant a...
Hi Stan! It is good to hear from you -- I am so very happy you are doing well. I agree with Janine that family and friends - our chosen family...
Recent Comments
I understand…